Copart (CPRT) director exercises 100k options, sells shares on Form 4

Q: What prices were involved in the Copart (CPRT) director’s Form 4 transactions?

The stock options were exercised at $11.8 per share. The 100,000 common shares were sold at a weighted average price of $39.07 per share, with individual sale prices ranging from $39.00 to $39.14.

Q: How many Copart (CPRT) shares did the insider own after the reported transactions?

After the reported transactions on 11/25/2025, the director reported 0 shares of Copart common stock and 0 derivative securities (stock options) as beneficially owned directly.

Q: What type of derivative security was involved in the Copart (CPRT) Form 4?

The derivative security was a stock option giving the right to acquire 100,000 shares of Copart common stock at an exercise price of $11.8 per share. After exercising these options, the remaining reported option balance was 0.

Q: What was the expiration date of the Copart (CPRT) stock options that were exercised?

The exercised stock options had an expiration date of 12/17/2025. The Form 4 notes that these options vested on a monthly basis over the 12 months succeeding the grant date.

Q: Who signed the Copart (CPRT) Form 4 for the reporting person?

The Form 4 was signed by /s/ D. Joseph Meister, attorney-in-fact on behalf of the reporting person.

Copart, Inc. (CPRT) director reports an option exercise and share sale.

Accepted by SEC EDGAR 11/25/2025 - 06:11 PM EST

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Copart, Inc. (CPRT) director reports an option exercise and share sale. On 11/25/2025, the reporting person exercised stock options for 100,000 shares of Copart common stock at an exercise price of $11.8 per share. On the same date, they sold 100,000 shares of common stock in the open market at a weighted average price of $39.07 per share, with individual sale prices ranging from $39.00 to $39.14. Following these transactions, the reported direct holdings of both the underlying stock options and common shares were 0.

Insider Trade Summary

Exercise and Sale: 100,000 shares ($2.73M approx. pre-tax spread)

Exercise and Sale 3 txns

Insider TRYFOROS THOMAS N

Role Director

Sold 100,000 shs ($3.91M)

Approx. gross sale proceeds $3.91M

Approx. exercise cost $1.18M

Approx. pre-tax spread $2.73M

Share of Position Sold 100%

Type	Security	Shares	Price	Value
Exercise	Stock Option	100,000	$0.00	$0.00
Exercise	Common Stock	100,000	$11.80	$1.18M
Sale	Common Stock	100,000	$39.07	$3.91M

Holdings After Transaction: Stock Option — 0 contracts (Direct); Common Stock — 0 shares (Direct)

Holdings Before and After: Stock Option, 100,000 to 0 contracts (Direct); Common Stock, 0 to 0 shares (Direct)

Footnotes (2)

F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.00 to $39.14, inclusive. The reporting person undertakes to provide to Copart, Inc., any security holder of Copart, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
F2. Options vested on a monthly basis over the 12 months succeeding the grant date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Copart (CPRT) report on this Form 4?

The filing shows a Copart, Inc. director exercised stock options for 100,000 shares of common stock at an exercise price of $11.8 per share and sold 100,000 shares of common stock in the open market on 11/25/2025.

What prices were involved in the Copart (CPRT) director’s Form 4 transactions?

The stock options were exercised at $11.8 per share. The 100,000 common shares were sold at a weighted average price of $39.07 per share, with individual sale prices ranging from $39.00 to $39.14.

How many Copart (CPRT) shares did the insider own after the reported transactions?

After the reported transactions on 11/25/2025, the director reported 0 shares of Copart common stock and 0 derivative securities (stock options) as beneficially owned directly.

What type of derivative security was involved in the Copart (CPRT) Form 4?

The derivative security was a stock option giving the right to acquire 100,000 shares of Copart common stock at an exercise price of $11.8 per share. After exercising these options, the remaining reported option balance was 0.

What was the expiration date of the Copart (CPRT) stock options that were exercised?

The exercised stock options had an expiration date of 12/17/2025. The Form 4 notes that these options vested on a monthly basis over the 12 months succeeding the grant date.

Who signed the Copart (CPRT) Form 4 for the reporting person?

The Form 4 was signed by /s/ D. Joseph Meister, attorney-in-fact on behalf of the reporting person.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

TRYFOROS THOMAS N

(Last)

(First)

(Middle)

C/O COPART, INC. 14185 DALLAS PARKWAY

SUITE 300

(Street)

DALLAS

75254

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
COPART INC [ CPRT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	11/25/2025		M		100,000	A	$11.8	100,000	D
Common Stock	11/25/2025		S		100,000	D	$39.07⁽¹⁾	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option	$11.8	11/25/2025		M			100,000	⁽²⁾	12/17/2025	Common Stock	100,000	$0	0	D

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.00 to $39.14, inclusive. The reporting person undertakes to provide to Copart, Inc., any security holder of Copart, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.

2. Options vested on a monthly basis over the 12 months succeeding the grant date.

Remarks:

	/s/ D. Joseph Meister, attorney-in-fact	11/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR